SIECZKAREK MARK M 4
4 · NovaBay Pharmaceuticals, Inc. · Filed Aug 6, 2019
Insider Transaction Report
Form 4
SIECZKAREK MARK M
Director
Transactions
- Award
Common Stock
2019-07-30+167,938→ 1,156,883 total
Footnotes (1)
- [F1]On July 30, 2019, Mr. Sieczkarek was issued 167,938 restricted stock units ("RSUs") with a fair market value equal to $220,000 from the Company's 2017 Omnibus Incentive Plan, which were immediately fully vested into common stock. Such RSUs were granted to Mr. Sieczkarek in relation to a Severance Agreement and General Release, as disclosed in the Company's Current Report on Form 8-K, filed with the SEC on July 25, 2019.